1636
K. Daragics et al. / Carbohydrate Research 346 (2011) 1633–1637
1.4. General procedure for reductive ring openings with
BH3ÁNMe3–AlCl3
J 11.5 Hz, 1/2PhCH2), 4.91 (d, 1H, J 11.5 Hz, 1/2PhCH2), 5.13 (d,
1H, J1,2 3.6 Hz, H-1), 5.17 (dd, 1H, J1,2 3.6 Hz, J2,3 9.5 Hz, H-2),
7.24–7.40 (m, 10H, aromatic), 7.46–7.51 (m, 2H, aromatic), 7.59–
7.63 (m, 1H, aromatic), 8.13–8.15 (m, 2H, aromatic); 13C NMR
(75 MHz, CDCl3): d 55.1 (OMe), 69.6 (C-6), 69.9 (C-5), 71.3 (C-4),
73.7 (C-2), 73.5 (PhCH2), 75.0 (PhCH2), 79.6 (C-3), 97.1 (C-1),
127.49, 127.53, 127.6, 127.7, 128.3, 129.6, 129.7, 133.1, 137.8,
138.2 (aromatic), 165.7 (PhCO). MS-ESI: [MÀOMe]+ 447.2,
[M+H]+ 479.2, [M+Na]+ 501.3, [M+K]+ 517.2.
A solution of aluminium chloride (1.07 g, 8.0 mmol, 2 equiv) in
dry diethyl ether (10 mL) was added during 10 min to a stirred
mixture of the benzylidene derivative (1a–1e) (4.0 mmol) and bor-
ane trimethylamine (1.46 g, 20 mmol, 5 equiv) in dry dichloro-
methane (50 mL) at 0 °C. After completion of the reaction, the
mixture was diluted with dichloromethane (100 mL) and stirred
with 2 M aq HCl (100 mL) for 2 h. The organic layer was washed
with saturated aq NaHCO3 and water, dried (MgSO4), and concen-
trated. The products were isolated by silica gel column chromatog-
raphy (toluene–acetone, 98:2?4:1).
Eluted next was methyl 2-O-benzoyl-3,4-di-O-benzyl-
glucopyranoside (2c) (1.461 g, 76%). White crystals: mp 99–
100 °C (from ethyl acetate–hexanes), lit.21 white solid; [
+148
a-D-
a]
D
(c 0.67, chloroform). 1H NMR (300 MHz, CDCl3): d 2.02 (dd, 1H,
J6a,OH 5.5 Hz, J6b,OH 7.3 Hz, OH), 3.35 (s, 3H, OMe), 3.67–3.88 (m,
4H, H-4, H-5, H-6a, H-6b), 4.21 (dd, 1H, J2,3 ꢀ J3,4 9.5 Hz, H-3),
4.69 (d, 1H, J 11.0 Hz, 1/2PhCH2), 4.83 (s, 2H, PhCH2), 4.89 (d, 1H,
J 11.0 Hz, 1/2PhCH2), 5.03 (d, 1H, J1,2 3.6 Hz, H-1), 5.08 (dd, 1H,
J1,2 3.6 Hz, J2,3 9.5 Hz, H-2), 7.16–7.32 (m, 10H, aromatic), 7.40–
7.46 (m, 2H, aromatic), 7.54–7.59 (m, 1H, aromatic), 8.05–8.07
(m, 2H, aromatic); 13C NMR (75 MHz, CDCl3): d 55.1 (OMe), 61.7
(C-6), 70.9 (C-5), 74.1 (C-2), 75.1 (PhCH2), 75.5 (PhCH2), 77.6 (C-
4), 79.9 (C-3), 97.2 (C-1), 127.6, 127.8, 128.0, 128.3, 128.4, 129.6,
129.8, 133.2, 138.0, 138.1 (aromatic), 165.9 (PhCO).
1.5. Reductive ring opening of methyl 2,3-di-O-benzyl-4,6-O-
benzylidene-a-D-glucopyranoside (1a)
Eluted first from the column was methyl 2,3,6-tri-O-benzyl-
a
+14
-
D
-glucopyranoside (3a) (0.317 g, 17%). Colorless syrup: [
(c 0.64, chloroform), lit.3 +9, lit.6 +11, lit.14
lit.15 +14, lit.16 +15.1. MS-ESI: [M+NH4]+ 482.3, [M+Na]+
[a]
D
a
]
D
[
a]
[
a]
[
a] +13,
D
D
D
[
a]
D
487.3, [M+K]+ 503.2. The 1H and 13C NMR data were in agreement
with those reported.16,17
Eluted second was methyl 2,3,4-tri-O-benzyl-a-D-glucopyrano-
side (2a) (1.432 g, 77%). White crystals: mp 50–51 °C (from ethyl
1.8. Reductive ring opening of methyl 3-O-benzoyl-2-O-benzyl-
4,6-O-benzylidene-a-D-glucopyranoside (1d)
acetate–hexanes), lit.6 mp 53–54 °C, lit.16 mp 43–44 °C, lit.17 oil;
lit.18 mp 65–67 °C, lit.19 mp 50–51 °C; [
a]D +24 (c 0.74, chloroform),
lit.6 [
a
]
D +22.5, lit.18
[a
]
D +24, lit.19
[a
]
D +22, lit.20
[a
]
D +26.3. The 1H
Eluted first was a syrup (0.017 g, 1%) which had 1H, 13C NMR
and MS spectra indistinguishable from those of methyl 2,3,6-tri-
and 13C NMR data were in agreement with those reported.16,20
O-benzyl-
The next compound obtained was methyl 3-O-benzoyl-2,6-di-
O-benzyl- -glucopyranoside (3d) (0.107 g, 6%). Colorless syrup:
+71 (c 0.47, chloroform). 1H NMR (300 MHz, CDCl3): d 3.06
a-D-glucopyranoside (3a).
1.6. Reductive ring opening of methyl 2,3-di-O-benzoyl-4,6-O-
benzylidene-
a
-D
-glucopyranoside (1b)
a-D
[a]
D
Eluted first from the column was a fraction, which turned out to
be a mixture of two compounds. The components were separated
by column chromatography using hexanes–acetone (9:1) as eluent.
The first compound proved to be methyl 2-O-benzoyl-3,6-di-O-
(br s, 1H, OH), 3.40 (s, 3H, OMe), 3.68 (dd, 1H, J1,2 3.5 Hz, J2,3
9.8 Hz, H-2), 3.70–3.80 (m, 4H, H-4, H-5, H-6a, H-6b), 4.55 (d,
1H, J 12.1 Hz, 1/2PhCH2), 4.59 (d, 1H, J 12.1 Hz, 1/2PhCH2), 4.61
(d, 1H, J 12.6 Hz, 1/2PhCH2), 4.64 (d, 1H, J 12.6 Hz, 1/2PhCH2),
4.75 (d, 1H, J1,2 3.5 Hz, H-1), 5.51 (dd, 1H, J2,3 ꢀ J3,4 9.8 Hz, H-3),
7.22–7.32 (m, 10H, aromatic), 7.40–7.45 (m, 2H, aromatic), 7.53–
7.58 (m, 1H, aromatic), 8.01–8.03 (m, 2H, aromatic); 13C NMR
(75 MHz, CDCl3): d 55.2 (OMe), 69.1 (C-6), 70.2 and 70.3 (C-4 and
C-5), 72.8 (PhCH2), 73.5 (PhCH2), 76.1 (C-3), 76.4 (C-2), 97.7 (C-
1), 127.5, 127.8, 127.9, 128.3, 129.7, 129.8, 133.1, 137.6, 137.8 (aro-
matic), 167.4 (PhCO). MS-ESI: [M+H]+ 479.3, [M+NH4]+ 496.4,
[M+Na]+ 501.5, [M+K]+ 517.2. Anal. Calcd for C28H30O7: C, 70.28;
H, 6.32. Found: C, 70.19, H, 6.35.
benzyl-a-D
-glucopyranoside (3c) (0.018 g, 1%). Its 1H, 13C NMR
and MS spectra were indistinguishable from the ones described
for this compound in Section 1.7. The second component of this
mixture was methyl 2,3-di-O-benzoyl-6-O-benzyl-
a-D-glucopy-
ranoside (3b) (0.149 g, 8%). Colorless syrup: [ D +123 (c 0.63, chlo-
a]
roform), lit.14
[
a]
+113. The 1H and 13C NMR data were in
D
agreement with those reported.20
Continued elution of the original column with toluene–acetone
gave next methyl 2,3-di-O-benzoyl-4-O-benzyl-
side (2b) (0.811 g, 41%). White crystals: mp 112–113 °C (from ethyl
acetate–hexanes), lit.3 mp 117–118 °C; [
+133 (c 0.80, chloro-
a-D-glucopyrano-
The following compound eluted was methyl 3-O-benzoyl-2,4-
a
]
D
di-O-benzyl-a-D-glucopyranoside (2d) (1.062 g, 55%). Colorless
form), lit.3
[
a]
+132, lit.20
[
a]
D
+140.9. The 1H and 13C NMR data
syrup: [a] [a]
+36 (c 0.62, chloroform), lit.5 +36. The 1H and 13C
D D
D
were in agreement with those reported.20
NMR data were in agreement with those reported.5
Further elution afforded a compound which proved to be
The next fraction proved to be methyl 2,6-di-O-benzyl-a-D-
methyl 2-O-benzoyl-6-O-benzyl-
a
-
D
-glucopyranoside (4) (0.206 g,
+99 (c 0.62, chloroform),
glucopyranoside (3e) (0.439 g, 29%). White crystals: mp 74–75 °C
13%). White crystals: mp 87–88 °C; [
a
]
D
(from ethyl acetate–hexanes), lit.18 mp 85–86 °C, lit.22 mp 80–
lit.20
[
a
]
+88.7. MS-ESI: [M+H]+ 389.4, [M+Na]+ 411.2, [M+K]+
82 °C; [
+58.7, lit.23
with those reported.22,23
a]
D
+63 (c 0.63, chloroform), lit.18
[a]
+62.6, lit.22
[a]
D D
D
427.0. The 1H and 13C NMR data were in agreement with those
reported.20
[a]
D +63.2. The 1H and 13C NMR data were in agreement
1.7. Reductive ring opening of methyl 2-O-benzoyl-3-O-benzyl-
1.9. Reductive ring opening of methyl 2-O-benzyl-4,6-O-
benzylidene- -glucopyranoside (1e)
4,6-O-benzylidene-
a
-D
-glucopyranoside (1c)
a-D
Eluted first was methyl 2-O-benzoyl-3,6-di-O-benzyl-
glucopyranoside (3c) (0.288 g, 15%). Colorless syrup: [ +98 (c
0.60, chloroform), lit.9 +99. 1H NMR (300 MHz, CDCl3): d
2.92 (br s, 1H, OH), 3.42 (s, 3H, OMe), 3.80–3.92 (m, 4H, H-4, H-
5, H-6a, H-6b), 4.11 (dd, 1H, J2,3 ꢀ J3,4 9.5 Hz, H-3), 4.63 (d, 1H, J
12.0 Hz, 1/2PhCH2), 4.69 (d, 1H, J 12.0 Hz, 1/2PhCH2), 4.82 (d, 1H,
a
-
D
-
Eluted first from the column was methyl 2,4-di-O-benzyl-a-D-
a]
D
glucopyranoside (2e) (0.488 g, 33%). White crystals: mp 64–65 °C
[a]
D
(from ethyl acetate–hexanes), lit.18 mp 75 °C, lit.24 mp 71–72 °C,
lit.25 mp 74–75 °C; [
a
[
]
a
+100 (c 0.72, chloroform), lit.18
]
[a]
+87,
D
D
lit.24
[
a]
D
+98.3, lit.25
+88. The 1H and 13C NMR data were in
D
agreement with those reported.24